Switch to: References

Add citations

You must login to add citations.
  1. HIV prevention research and COVID-19: putting ethics guidance to the test.Jeremy Sugarman, Steven Wakefield, Brandon Brown, Ernest Moseki, Robert Klitzman, Florencia Luna, Leah A. Schrumpf, Wairimu Chege & Stuart Rennie - 2021 - BMC Medical Ethics 22 (1):1-10.
    BackgroundCritical public health measures implemented to mitigate the spread of the novel coronavirus disease (COVID-19) pandemic have disrupted health research worldwide, including HIV prevention research. While general guidance has been issued for the responsible conduct of research in these challenging circumstances, the contours of the dueling COVID-19 and HIV/aids pandemics raise some critical ethical issues for HIV prevention research. In this paper, we use the recently updated HIV Prevention Trials Network (HPTN) Ethics Guidance Document (EGD) to situate and analyze key (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  • Ethical considerations for HIV remission clinical research involving participants diagnosed during acute HIV infection.Stuart Rennie, Maartje Dijkstra, Karine Dubé, Joseph D. Tucker & Adam Gilbertson - 2021 - BMC Medical Ethics 22 (1):1-12.
    HIV remission clinical researchers are increasingly seeking study participants who are diagnosed and treated during acute HIV infection—the brief period between infection and the point when the body creates detectable HIV antibodies. This earliest stage of infection is often marked by flu-like illness and may be an especially tumultuous period of confusion, guilt, anger, and uncertainty. Such experiences may present added ethical challenges for HIV research recruitment, participation, and retention. The purpose of this paper is to identify potential ethical challenges (...)
    No categories
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
    		•
  • Ensuring Access to HIV Prevention Services in South African HIV Vaccine Trials: Correspondence Between Guidelines and Practices.Zaynab Essack - 2014 - Public Health Ethics 7 (2):195-206.
    Researchers and sponsors are required to assist HIV prevention trial participants to remain HIV-uninfected by ensuring access to prevention services. Ethics guidelines require that these HIV risk-reduction services be state of the art. This and related ethics recommendations have been intensely debated. This descriptive study aimed to identify actual HIV prevention practices for two HIV vaccine trials at five South African sites, to explore whether actual practices meet guideline recommendations and to discuss implications for practices and ethics guidelines. Practices were (...)
    Direct download (8 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  • Addressing ethical challenges in HIV prevention research with people who inject drugs.Liza Dawson, Steffanie A. Strathdee, Alex John London, Kathryn E. Lancaster, Robert Klitzman, Irving Hoffman, Scott Rose & Jeremy Sugarman - 2018 - Journal of Medical Ethics 44 (3):149-158.
    Despite recent advances in HIV prevention and treatment, high HIV incidence persists among people who inject drugs. Difficult legal and political environments and lack of services for PWID likely contribute to high HIV incidence. Some advocates question whether any HIV prevention research is ethically justified in settings where healthcare system fails to provide basic services to PWID and where implementation of research findings is fraught with political barriers. Ethical challenges in research with PWID include concern about whether research evidence will (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   8 citations  
  • Addressing ethical challenges in HIV prevention research with people who inject drugs.Liza Dawson, Steffanie A. Strathdee, Alex John London, Kathryn E. Lancaster, Robert Klitzman, Irving Hoffman, Scott Rose & Jeremy Sugarman - 2018 - Journal of Medical Ethics Recent Issues 44 (3):149-158.
    Despite recent advances in HIV prevention and treatment, high HIV incidence persists among people who inject drugs. Difficult legal and political environments and lack of services for PWID likely contribute to high HIV incidence. Some advocates question whether any HIV prevention research is ethically justified in settings where healthcare system fails to provide basic services to PWID and where implementation of research findings is fraught with political barriers. Ethical challenges in research with PWID include concern about whether research evidence will (...)
    No categories
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   8 citations